Scott Blumberg is an Analyst at Bay City Capital and has been with the firm since August 2006. Mr. Blumberg is responsible for developing financial analyses and conducting research for Bay City Capital's venture investments and related activities. He is involved in several Fund IV investments, including IDev Technologies and Conatus Pharmaceuticals. Prior to joining Bay City Capital, Mr. Blumberg was an Investment Banking Analyst in the Healthcare group at Banc of America Securities, where he worked on a number of M&A and corporate finance transactions for a variety of healthcare clients. Mr. Blumberg graduated cum laude from Dartmouth College, receiving an AB in Economics and a Minor in Psychology.